Takeda's QDENGA becomes first dengue vaccine approved in India
20/07/2026 06:55
Takeda's QDENGA becomes first dengue vaccine approved in India July 20 (Reuters) - Japanese drugmaker Takeda Pharmaceutical's 4502.T dengue vaccine QDENGA has been approved by India's drug regulator, making it the first dengue vaccine to be approved in the country, the company's Indian unit said on Monday.
(Reporting by Rishika Sadam; Editing by Janane Venkatraman)
Recent news on Takeda Pharmaceutical
See all newsTakeda launches sleep disorder pill in the US after DEA clearance removes final hurdle (updated)
Brief: Takeda's Orzeyful Available In U.S. By Prescription To Treat Narcolepsy Type 1 In Adults
Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle
Takeda Pharmaceutical Company Limited reports results for the quarter ended September 30 - Earnings Summary
Table: Takeda Pharmaceutical Company Limited -6-MTH group results (IFRS)